management of platinum resistant ovarian cancer, detailed overview using all evidences, including latest evidences, choice of chemotherapy, factors deciding choice of chemotherapy.using tables and flowcharts wherever required give the document in pdf format
"platinum-resistant ovarian cancer" AND treatment
platinum resistant ovarian cancer management guidelines 2024 2025 chemotherapy NCCN ESMO
platinum resistant ovarian cancer management chemotherapy choice factors
"ovarian cancer" AND "antibody drug conjugate" AND "platinum resistant"
"platinum resistant ovarian cancer" AND immunotherapy AND pembrolizumab
"platinum resistant ovarian cancer" AND PARP inhibitor rucaparib
KEYNOTE-B96 pembrolizumab paclitaxel bevacizumab platinum resistant ovarian cancer results 2025
"ovarian cancer" AND "AURELIA" AND bevacizumab chemotherapy